ABSTRACT SUBMISSION

23rd MSH ASM 2026 Abstract Submission Guidelines

Key Dates & Deadlines

Abstract Submission Opens

1 April 2026

Abstract Submission Deadline

5 June 2026,
11.59 pm (GMT +8)

Notification To Authors

26 June 2026

Presenting Author Registration Deadline

1 July 2026

Abstract Eligibility & General Instructions

  1. Abstracts must be submitted electronically via the official abstract submission portal and accessible via the conference website at www.msh2026.com. Submissions by email or post will not be accepted.
  2. Abstracts must be written and presented in English. Submissions in other languages will be declined.
  3. Abstracts must be prepared using Arial font, size 11, and follow the prescribed abstract structure.
  4. Abbreviations should be defined at first mention and used consistently throughout the abstract.
  5. Only complete and properly submitted abstracts will be considered. Incomplete submissions will be rejected.
  6. Abstracts will be published exactly as submitted. Authors are responsible for ensuring accuracy, clarity, correct spelling and grammar.
  7. The MSH 2026 Scientific Programme Committee reserves the right to reject abstracts that are poorly written or to request immediate revision to improve readability.
  8. Authors are responsible for obtaining ethics approval or applicable regulatory requirements. For case reports or case series, patient consent must be obtained, and all identifiable patient information must be omitted.

Abstract Structure

Title
  • Capitalise the first letter of each word.
  • Limited to a maximum of 30 words.

Authors’ name:

  • List all authors in full name format (first name followed by last name)
  • Underline the presenting author
  • Do not include academic titles or degree qualifications


Affiliation
should be structured as follows:

  • Department, Institution, City, State, Country


The email address of the presenting author should be provided.

Clinical research studies should be structured as:

  • Background and Aims
  • Methods
  • Results
  • Conclusions


Case studies or case series should be structured as:

  • Introduction or Background
  • Clinical Case (including diagnostic evaluation, treatment, and follow-up)
  • Clinical Lesson(s) or Conclusion(s) (emphasising the learning point[s] and implications for clinical practice)


Limited to a maximum of 300 words.

No more than 3 keywords are allowed.

Only one table or figure is allowed.